OpenAlex
PricingAboutJobs
Log inGet started
Work

Molecular Pathways: How Can BRCA-Mutated Tumors Become Resistant to PARP Inhibitors?

HTML

Year: 2013
Type: review
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-13-0225
Authors: Peter Bouwman, Jos Jonkers
Institution: The Netherlands Cancer Institute
Language: English

Topic: PARP inhibition in cancer therapy
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: PARP inhibitors, BRCA1, BRCA2, PARP inhibitor resistance, synthetic lethality, homologous recombination, DNA repair, genetic reversion, drug efflux pumps, DNA damage response, patient stratification, ovarian cancer, breast cancer
SDG: Good health and well-being

Open Access status: closed

Funder: Nederlandse Organisatie voor Wetenschappelijk Onderzoek
Award: A systems biology approach to construct computational models for predicting response to therapy in breast cancer
OpenAlex ID: W2102967423
FWCI: 2.062
Cites: 67
Cited by: 173
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms